Standard

IDO inhibitors increase the antitumor immunity of ICD-dying cells. / Troitskaya, O.; Varlamov, M.; Kuligina, E. et al.

In: FEBS Open Bio, Vol. 11, 07.2021, p. 401-402.

Research output: Contribution to journal › Meeting Abstract › peer-review

Harvard

Troitskaya, O, Varlamov, M, Kuligina, E, Richter, V & Koval, O 2021, 'IDO inhibitors increase the antitumor immunity of ICD-dying cells', FEBS Open Bio, vol. 11, pp. 401-402.

APA

Troitskaya, O., Varlamov, M., Kuligina, E., Richter, V., & Koval, O. (2021). IDO inhibitors increase the antitumor immunity of ICD-dying cells. FEBS Open Bio, 11, 401-402.

Vancouver

Troitskaya O, Varlamov M, Kuligina E, Richter V, Koval O. IDO inhibitors increase the antitumor immunity of ICD-dying cells. FEBS Open Bio. 2021 Jul;11:401-402.

Author

Troitskaya, O. ; Varlamov, M. ; Kuligina, E. et al. / IDO inhibitors increase the antitumor immunity of ICD-dying cells. In: FEBS Open Bio. 2021 ; Vol. 11. pp. 401-402.

BibTeX

@article{5511593a82154854bd98c62df95975b0,
title = "IDO inhibitors increase the antitumor immunity of ICD-dying cells",
author = "O. Troitskaya and M. Varlamov and E. Kuligina and V. Richter and O. Koval",
note = "This work was supported by RFBR grant No 19-34-90134.",
year = "2021",
month = jul,
language = "English",
volume = "11",
pages = "401--402",
journal = "FEBS Open Bio",
issn = "2211-5463",
publisher = "John Wiley & Sons Inc.",

}

RIS

TY - JOUR

T1 - IDO inhibitors increase the antitumor immunity of ICD-dying cells

AU - Troitskaya, O.

AU - Varlamov, M.

AU - Kuligina, E.

AU - Richter, V.

AU - Koval, O.

N1 - This work was supported by RFBR grant No 19-34-90134.

PY - 2021/7

Y1 - 2021/7

M3 - Meeting Abstract

VL - 11

SP - 401

EP - 402

JO - FEBS Open Bio

JF - FEBS Open Bio

SN - 2211-5463

ER -

ID: 34745931